Nachrichten zur Vertex Pharmaceuticals Inc. Aktie

Vertex Pharmaceuticals Incorporated 2024 Q3 - Results - Earnings Call Presentation

…

Vertex Pharmaceuticals: Kursziel gesenkt

New York (www.aktiencheck.de) - Rating-Update: Die Analysten der Oppenheimer senken das Kursziel für die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits

Its latest report of clinical data suggests it has a winner on its hands.…

Vertex Pharmaceuticals Just Found Its Newest Blockbuster Drug. A $41 Billion Market Awaits @themotleyfool #stocks $VRTX

Its latest report of clinical data suggests it has a winner on its hands.…

Vertex Pharmaceuticals: A Long-Term Growth Monster

…

Vertex Pharmaceuticals: The Future Looks Bright, But It May Be A Choppy Ride

…

Vertex Pharmaceuticals Aktie: Wachstum durch CF-Franchise und Pipeline-Potenzial!

Charlotte (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BofA Securities: Rating und Kursziel BofA-Analyst Geoff Meacham hat das Kursziel für Vertex Pharmaceuticals Inc. (ISIN:…

Vertex Pharmaceuticals Aktie: Phase 2 Ergebnisse zu Suzetrigine entscheidend

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von RBC Capital Markets: Rating und Kursziel RBC Capital Markets hat das Kursziel für die Aktie von…

Vertex Pharmaceuticals Aktie: Fair bewertet?

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Morgan Stanley: 1. Anpassung des Kursziels und Bewertung - Morgan Stanley hat das Kursziel für…

The Best Biotech Stock to Invest $1,000 in Right Now

Vertex Pharmaceuticals isnt an ordinary biotech stock.…

The Best Biotech Stock to Invest $1,000 in Right Now @themotleyfool #stocks $VRTX

Vertex Pharmaceuticals isnt an ordinary biotech stock.…

The Best Biotech Stock to Invest $1,000 in Right Now

Vertex Pharmaceuticals isnt an ordinary biotech stock.…

Vertex Pharmaceuticals, Inc. (VRTX) Morgan Stanley 22nd Annual Global Healthcare Conference (Transcript)

…

Vertex Pharmaceuticals: Is The Recent Barclays Downgrade Justified? Im Not Convinced

…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow

Vertex should have a future full of bright tomorrows.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX

Vertex should have a future full of bright tomorrows.…

Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead

Vertex Pharmaceuticals has a lot going for it.…

Analyst Report: Vertex Pharmaceuticals, Inc.

…

Is It Too Late to Buy Vertex Pharmaceuticals Stock?

Shares of the rare disease drugmaker are already up more than 40% over the past year.…

Is It Too Late to Buy Vertex Pharmaceuticals Stock? @themotleyfool #stocks $VRTX $MRK $PFE $CRSP

Shares of the rare disease drugmaker are already up more than 40% over the past year.…

Vertex Pharmaceuticals: Umsatzprognose angehoben - Aktienanalyse

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Oppenheimer: Oppenheimer hebt in einer aktuellen Aktienanalyse das Kursziel für die Aktie von Vertex…

Vertex Pharmaceuticals: Gute Logik - Aktienanalyse

Charlotte, NC (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Truist: Joon Lee, Analyst von Truist, stuft in einer aktuellen Aktienanalyse die Aktie von…

Vertex Pharmaceuticals: Abstufung wegen Bewertung, neues Kursziel - Aktienanalyse

London (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Barclays: Barclays stuft in einer aktuellen Aktienanalyse die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003,…

Vertex Pharmaceuticals: Kursziel um 100 USD angepasst

New York (www.aktiencheck.de) - Rating-Update: Andrew Fein, Analyst von H.C. Wainwright & Co, empfiehlt die Aktie von Vertex Pharmaceuticals Inc. (ISIN:…

Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript

VRTX earnings call for the period ending June 30, 2024.…

Vertex Pharmaceuticals: Kursziel angehoben

Vancouver (www.aktiencheck.de) - Rating-Update: Die Analysten von Canaccord Genuity bewerten die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN: 882807, Ticker-Symbol:…

Vertex Pharmaceuticals: Kursziel vor Q2-Zahlen angehoben - Aktienanalyse

San Francisco (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Citizens JMP Securities: Die Analysten von Citizens JMP Securities heben in einer aktuellen Aktienanalyse…

Is Vertex Pharmaceuticals Monopoly in Danger?

As a shareholder, I am nowhere close to panic mode.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow @themotleyfool #stocks $VRTX

Vertex shares have soared by triple-digit percentages over the past three years.…

3 Reasons to Buy Vertex Pharmaceuticals Stock Like Theres No Tomorrow

Vertex shares have soared by triple-digit percentages over the past three years.…

Vertex Pharmaceuticals: Günstiges Chance/Risiko-Verhältnis - Aktienanalyse

Milwaukee (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Robert W. Baird: Die Analysten von Robert W. Baird nehmen die Coverage der Aktie von…

Vertex Pharmaceuticals: Alpine-Übernahme im Fokus - Kursziel auf 500 USD erhöht - Aktienanalyse

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von H.C. Wainwright & Co.: Die Analysten von H.C. Wainwright & Co. stufen die Aktie…

Vertex Pharmaceuticals EVP and CMO sells $1.1M in stock By Investing.com

Vertex Pharmaceuticals EVP and CMO sells $1.1M in stock…

Did Vertex Pharmaceuticals Just Invent the Next Ozempic?

Vertex Pharmaceuticals likely has a breakthrough medicine on its hands.…

Vertex Pharmaceuticals: Coverage aufgenommen

London (www.aktiencheck.de) - Rating-Update: Die Analysten von Redburn Atlantic nehmen die Coverage der Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Verve Therapeutics Announces Appointment of Nia Tatsis, Ph.D., and Jodie Morrison to its Board of Directors

BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Verve Therapeutics, a clinical-stage biotechnology company pioneering a new approach to…

Vertex Pharmaceuticals: Neues Kursziel

San Francisco (www.aktiencheck.de) - Rating-Update: Die Analysten von Wells Fargo Advisors stufen die Aktie von Vertex Pharmaceuticals Inc. (ISIN: US92532F1003, WKN:…

Vertex Pharmaceuticals: Fortschritte in der Pipeline, M&A-Aktivitäten und finanzielle Stärke im Fokus - Aktienanalyse

New York (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von Argus Research: Jasper Hellweg, Analyst von Argus Research, erhöht in einer aktuellen Aktienanalyse sein…

Analyst Report: Vertex Pharmaceuticals, Inc.

…

Cystic Fibrosis Therapeutics Global Strategic Business Report 2023-2030 Featuring Key Players - AbbVie, Galapagos, Genentech, Gilead Sciences, Novartis, and Vertex Pharmaceuticals

Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Therapeutics - Global Strategic Business Report" report has…

Vertex Pharmaceuticals: Kursziel gekappt

Toronto (www.aktiencheck.de) - Rating-Update: Die Analysten vom Investmenthaus RBC Capital Markets bestätigen das "sector-perform"-Rating für die Aktie von Vertex Pharmaceuticals Inc.…

Vertex Pharmaceuticals: VX-548 im Fokus - Aktienanalyse

Toronto (www.aktiencheck.de) - Vertex Pharmaceuticals-Aktienanalyse von BMO Capital Markets: Die Analysten von BMO Capital Markets stufen die Aktie von Vertex Pharmaceuticals…

Is It Too Late to Buy Vertex Pharmaceuticals Stock?

Shares of the growing biotech company have doubled in three years.…

Is It Too Late to Buy Vertex Pharmaceuticals Stock? @themotleyfool #stocks $VRTX

Shares of the growing biotech company have doubled in three years.…

3 High-Flying Stocks That Could Soar Even More

The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.…

ADDvise receives order worth USD 1.4 million

Axelerist, an ADDvise Group company, has received an order from Vertex Pharmaceuticals, a global biotechnology company, for the sale and…

Vertex Pharmaceuticals executive sells shares worth over $13k By Investing.com

Vertex Pharmaceuticals executive sells shares worth over $13k…

Vertex Is Writing A New Playbook For Pharma R&D. And It’s Working.

Vertex Pharmaceuticals (NDAQ: VRTX) path to becoming a top 20 pharma company with over a $100 billion market cap has…

Vertex Pharmaceuticals Is Racing Towards a New Blockbuster: Why the Stock Is a Smart Buy

The biotechs shares dropped following its latest quarterly update, but that shouldnt matter to long-term investors.…

Vertex Pharmaceuticals: Höheres Kursziel

Boston, MA (www.aktiencheck.de) - Rating-Update: Die Analysten von Leerink Partners wiederholen ihre Empfehlung "outperform" für die Aktie von Vertex Pharmaceuticals Inc.…